Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Glioma IL13Rα2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis

  • The PLOS ONE Staff

Table 2, “IPA Pathways Associated With IL13Rα2 Expression in Patient Tumor Samples, IL13Rα2-positive Cell Lines, and Mesenchymal Signature Genes,” incorrectly appears as a duplicate of Table 1. The figure caption appears correctly. Please see the corrected Table 2 here.

thumbnail
Download:
Table 2. IPA Pathways Associated with IL13Rα2 Expression in Patient Tumor Samples, IL13Rα2-positive Cell Lines, and Mesenchymal Signature Genes.

https://doi.org/10.1371/journal.pone.0204463.t001

Reference

  1. 1. Brown CE, Warden CD, Starr R, Deng X, Badie B, Yuan Y-C, et al. (2013) Glioma IL13Rα2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis. PLoS ONE 8(10): e77769. https://doi.org/10.1371/journal.pone.0077769 pmid:24204956

Citation: The PLOS ONE Staff (2018) Correction: Glioma IL13Rα2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis. PLoS ONE 13(9): e0204463. https://doi.org/10.1371/journal.pone.0204463

Published: September 17, 2018

Copyright: © 2018 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.